Zobrazeno 1 - 10
of 146
pro vyhledávání: '"Kyoo‑Rok Han"'
Autor:
Hae Won Jung, Chang‐Yeon Kim, Seung‐Pyo Hong, Han‐Joon Bae, Ji Yong Choi, Jae Kean Ryu, Jin‐bae Lee, Kyoung‐Hoon Lee, Kyoo‐Rok Han, Dong‐Heon Yang, Chang‐Gyu Park, Gheol‐Woong Yu, Moo‐Yong Rhee, Sung‐Ji Park, Min‐Su Hyon, Joon‐Han Shin, Bum‐Kee Hong, Han‐Young Jin, Sung‐Yun Lee, Sang‐Hoon Seol, Sang‐Rok Lee, Song‐Yi Kim, Kwang‐Je Lee, Eun‐Joo Cho, Chang‐Wook Nam, Tae‐Ho Park, Ung Kim, Kee‐Sik Kim
Publikováno v:
The Journal of Clinical Hypertension, Vol 25, Iss 9, Pp 828-844 (2023)
Abstract The authors performed this study to investigate the efficacy and safety of a rosuvastatin (RSV)/amlodipine (AML) polypill compared with those of atorvastatin (ATV)/AML polypill. We included 259 patients from 21 institutions in Korea. Patient
Externí odkaz:
https://doaj.org/article/dcd367a8963148ea91c9d1000d664c1a
Autor:
Ki‑Bum Won, Seung‑Ho Hur, Yun‑Kyeong Cho, Hyuck‑Jun Yoon, Chang‑Wook Nam, Kwon‑Bae Kim, Jang‑Ho Bae, Dong‑Ju Choi, Young‑Keun Ahn, Jong‑Seon Park, Hyo‑Soo Kim, Rak‑Kyeong Choi, Donghoon Choi, Joon‑Hong Kim, Kyoo‑Rok Han, Hun‑Sik Park, So‑Yeon Choi, Jung‑Han Yoon, Hyeon‑Cheol Kwon, Seung-Woon Rha, Kyung‑Kuk Hwang, Do‑Sun Lim, Kyung‑Tae Jung, Seok‑Kyu Oh, Jae‑Hwan Lee, Eun‑Seok Shin, Kee‑Sik Kim
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/64d48bb42a3649cd90fbc37ca60efb23
Autor:
Sang-Ho Jo, Sung-Ji Park, Eung Ju Kim, Soo-Joong Kim, Hyun-Jae Cho, Jong-Min Song, Jinho Shin, Jin Joo Park, Joon-Han Shin, Kyoo-Rok Han, Dong-Ju Choi
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-8 (2018)
Abstract Background The efficacy of a combination of a calcium channel blocker (CCB) plus chlorthalidone (diuretic) versus a CCB plus an angiotensin receptor blocker (ARB) in patients not responding to CCB monotherapy has not been evaluated previousl
Externí odkaz:
https://doaj.org/article/0328ba9ff5a44336819310d6b6bee65b
Autor:
Jun Pil Yun, Jeehoon Kang, Kyung Woo Park, Kyungil Park, Doyeon Hwang, Jung-Kyu Han, Han-Mo Yang, Hyun-Jae Kang, Bon-Kwon Koo, In-Ho Chae, Keon-Woong Moon, Hyun Woong Park, Ki-Bum Won, Dong Woon Jeon, Kyoo-Rok Han, Si Wan Choi, Jae Kean Ryu, Myung Ho Jeong, Hyo-Soo Kim
Publikováno v:
JACC: Asia. 3:51-61
Autor:
Han Saem, Jeong, Soon Jun, Hong, Jin-Man, Cho, Ki Hoon, Han, Dong-Hun, Cha, Sang-Ho, Jo, Hyun-Jae, Kang, So-Yeon, Choi, Cheol Ung, Choi, Eun Jeong, Cho, Young-Hoon, Jeong, Hyeon-Cheol, Gwon, Byeong-Keuk, Kim, Sung Yun, Lee, Sang-Hyun, Kim, Jeong Cheon, Ahn, Young Joon, Hong, Woo-Shik, Kim, Seong-Ill, Woo, Tae-Ho, Park, Kyoo-Rok, Han
Publikováno v:
Clinical Therapeutics. 44:1310-1325
Pitavastatin is a unique lipophilic statin with moderate efficacy in lowering LDL-C levels by 30% to 50% with a tolerable safety profile. However, the efficacy of adding ezetimibe to pitavastatin in patients with dyslipidemia has not been well invest
Autor:
Ae-Young Her, Seung-Jung Park, Keum Soo Park, Jung-Sun Kim, Youngkeun Ahn, In-Ho Chae, Sung Chul Chae, Si Hoon Park, Bon-Kwon Koo, Kyoung Tae Jeong, Jeong Kyung Kim, Jei Keon Chae, Seung Jae Joo, Sung-Jin Hong, Young Jo Kim, Myeong Chan Cho, Donghoon Choi, Chul Min Ahn, Yong Hoon Kim, Tae Hoon Ahn, Deug Young Nah, Sang Hyun Lee, Myung Ho Jeong, Seung-Woon Rha, In Whan Seong, Hyeon-Cheol Gwon, Doo-Il Kim, Dong Kyu Jin, Hang-Jae Chung, Tae Ik Kim, Jeong Gwan Cho, Seung Uk Lee, Myoung Yong Lee, Sang-Wook Kim, Yangsoo Jang, Junghan Yoon, Jang Ho Bae, Seung Won Jin, Seung Ho Hur, Soo-Joong Kim, Jin Man Cho, Jin-Yong Hwang, Kyoo-Rok Han, Jae Young Rhew, Nae-Hee Lee, Chong Yun Rhim, Ki Bae Seung, Seung-Jea Tahk, Young-Youp Koh, Myeong Ki Hong, Byung Ok Kim, Byeong Keuk Kim, Ju-Young Yang, Moo Hyun Kim, Hyo-Soo Kim, Taek Jong Hong, Seung-Jun Lee, Kee-Sik Kim, Jang-Hyun Cho, Wook Sung Chung, Seok Kyu Oh, Chong Jin Kim, Seong-Wook Park, Jong Hyun Kim, Young Guk Ko
Publikováno v:
Atherosclerosis. 344:60-70
Because of paucity of published data, we evaluated the 2-year major clinical outcomes between early invasive (EI) and delayed invasive (DI) strategies according to the stage of chronic kidney disease (CKD) in patients with non-ST-segment elevation my
Autor:
Ki-Bum Won, Eun-Seok Shin, Jeehoon Kang, Han-Mo Yang, Kyung Woo Park, Kyoo-Rok Han, Keon-Woong Moon, Seok Kyu Oh, Ung Kim, Moo-Yong Rhee, Doo-Il Kim, Song-Yi Kim, Sung-Yun Lee, Jung-Kyu Han, Bon-Kwon Koo, Hyo-Soo Kim
Publikováno v:
Circulation journal : official journal of the Japanese Circulation Society.
This study evaluated the association of body mass index (BMI) with adverse clinical outcomes during chronic maintenance antiplatelet monotherapy after percutaneous coronary intervention (PCI) with drug-eluting stents (DES).Methods and Results: Overal
Autor:
Bon-Kwon Koo, Jeehoon Kang, Kyung Woo Park, Tae-Min Rhee, Han-Mo Yang, Ki-Bum Won, Seung-Woon Rha, Jang-Whan Bae, Nam Ho Lee, Seung-Ho Hur, Junghan Yoon, Tae-Ho Park, Bum Soo Kim, Sang Wook Lim, Yoon Haeng Cho, Dong Woon Jeon, Sang-Hyun Kim, Jung-Kyu Han, Eun-Seok Shin, Hyo-Soo Kim, Heesun Lee, Kyoo-Rok Han, Keon-Woong Moon, Seok Kyu Oh, Ung Kim, Moo-Yong Rhee, Doo-Il Kim, Song-Yi Kim, Sung-Yun Lee, Seung Uk Lee, Sang-Wook Kim, Seok Yeon Kim, Hui-Kyung Jeon, Kwang Soo Cha, Sang-Ho Jo, Jae Kean Ryu, Il-Woo Suh, Hyun-Hee Choi, Seoung-Il Woo, In-Ho Chae, Won-Yong Shin, Dae-Kyeong Kim, Ju Hyeon Oh, Myung Ho Jeong, Yong Hoon Kim
Publikováno v:
The Lancet. 397:2487-2496
Background Optimal antiplatelet monotherapy during the chronic maintenance period in patients who undergo coronary stenting is unknown. We aimed to compare head to head the efficacy and safety of aspirin and clopidogrel monotherapy in this population
Autor:
Hae Young Lee, Hyeon Cheol Gwon, Dong-Ju Choi, Pum Joon Kim, Woo Baek Chung, Seung-Woon Rha, Kyoo Rok Han, Si Wan Choi, Woo Shik Kim, Ki Hoon Han, Bum-Kee Hong, Kyung Tae Jung, Jei Keon Chae, Tae Ho Park, Eun-Seok Shin, Sung Ho Her, Myung Ho Jeong, So-Yeon Choi, Jong Min Lee, Jong Seon Park, Namsik Chung
Publikováno v:
Clinical Therapeutics. 42:2036-2048
Purpose Although the role of high-intensity lipid-lowering therapy in cardiovascular protection has broadened, concerns still exist about new-onset diabetes mellitus (NODM), especially in vulnerable patients. This study aimed to compare the effect of
Autor:
Kiyuk Chang, Jang Hwan Bae, Dae Young Hyun, Myung Ho Jeong, Dong-Ju Choi, Kyoo Rok Han, Tae Hoon Ahn, Doo Sun Sim, Si Wan Choi, Jong Seon Park, Kwang Soo Cha, Jin Yong Hwang, Seung Ho Hur, Jei Keon Chae, Hyo-Soo Kim, Seok Kyu Oh
Publikováno v:
Chonnam Medical Journal
The optimal dose of beta blockers after acute myocardial infarction (MI) remains uncertain. We evaluated the effectiveness of low-dose nebivolol, a beta1 blocker and a vasodilator, in patients with acute MI. A total of 625 patients with acute MI from